Bri Chem Stock Price, News & Analysis

Bri-Chem (OTC:BRYFF) announced a leadership and governance change effective November 10, 2025. The Board appointed Barry Hugghins as Chief Executive Officer and President, while he continues as Executive Chairman.

Mr. Hugghins will receive a nominal salary of $1 per annum as CEO and President. The Company also eliminated cash retainers for its Board; directors will be compensated exclusively with equity-based incentives going forward. Management says these moves align leadership pay with long-term shareholder value and reinforce focus on operational execution and financial performance.

Bri-Chem (TSX: BRYFF) announced on November 9, 2025 that Don Caron, CEO and former chairman, has departed the company effective immediately.

The Board of Directors has initiated a leadership transition, is overseeing interim management responsibilities, and has commenced a search for a permanent CEO. The company said it expects no disruption to ongoing operations and will provide further updates once a permanent appointment is made.

Board leadership emphasized commitment to operational discipline, customer service, and long-term growth while working to maintain alignment and stakeholder confidence.

Bri-Chem Corp. (BRYFF) held its Annual General and Special Meeting on September 16, 2025, in Edmonton, Alberta. The meeting saw strong shareholder participation with 77.05% of outstanding shares represented. Shareholders approved key resolutions including: setting the Board size at four directors (99.96% approval), electing four directors with 65.28% support each, appointing Kingston Ross Pasnak LLP as auditors (99.98% approval), and approving an advance notice by-law (99.87% approval).

All four director nominees - Barry Hugghins, John H. Cale, William Colby Swain, and Scott Gaudin - received identical voting results, with 34.72% of votes withheld, indicating some shareholder concerns with the board composition.

Bri-Chem Corp. (TSX: BRY) (OTCQB: BRYFF), a North American oilfield chemical distribution company, has filed its management information circular for the upcoming annual meeting on September 16, 2025. The company urges shareholders to vote for its four nominees using the YELLOW proxy form.

The meeting has become a contested election between Bri-Chem's nominees and a dissident group led by Barry Hugghins, who owns 14% of the company. The Board raises concerns about the dissident nominees' lack of public company experience and potential conflicts of interest. In contrast, Bri-Chem's nominees collectively own 15.6% of the company and possess relevant public company experience.

Bri-Chem Corp. (TSX: BRY), a North American oilfield chemical distribution company, reported its Q2 2025 financial results with consolidated sales of $20.5 million, up 7% year-over-year. The company achieved Adjusted EBITDA of $1.0 million, a 48% increase from Q2 2024, and improved its operating earnings by 24% to $772,000.

Key performance metrics include adjusted net earnings of $0.01 per diluted share, compared to a loss of $0.02 in Q2 2024. Working capital stood at $11.1 million, down 21% year-over-year. The US drilling fluids division saw a 7% sales increase to $12.3 million, while Canadian operations reached $1.7 million in sales.

The company expects flat to slightly declining rig activity across North America through 2025, with potential recovery in early 2026.

Bri-Chem Corp (TSX: BRY, OTCQB: BRYFF), a North American oilfield chemical distribution company, has rescheduled its annual general meeting from June 20 to September 16, 2025. The postponement is due to several factors, including the need to address a proxy contest from the Hugghins Group regarding alternative director nominees. Additionally, the company has adopted an Advance Notice By-Law that establishes guidelines for director nominations by shareholders. The by-law requires shareholders to provide timely notice for director nominations: at least 30 days before annual meetings, or within 10 days of the first public announcement if the meeting is less than 50 days away. For special meetings, notice must be given within 15 days of the first public announcement. The Advance Notice By-Law will be presented for shareholder ratification at the rescheduled meeting.

Cenatex Holdings LLC, holding a 14.0016% stake (3,701,040 shares) in Bri-Chem Corp (BRYFF), has initiated engagement with the company's board, management, and investors. Led by Barry Hugghins, Cenatex aims to improve Bri-Chem's performance and enhance long-term value through potential changes in board composition, management, business strategies, governance, capital structure, and strategic alternatives. The stake remains unchanged since their May 12, 2025 report. Cenatex may adjust its holdings based on various factors including market conditions, Bri-Chem's performance, and investment opportunities. The company will continue to review its position and may engage in further communications with stakeholders regarding improvements to Bri-Chem's operations.

Bri-Chem Corp (TSX: BRY), a North American oilfield chemical distributor, reported its Q1 2025 results with consolidated sales of $19.9 million, down 7% from Q1 2024. The company's financial performance showed mixed results:

- Adjusted EBITDA improved to $465,000 (2% of revenue) from -$443,000 (-2%) in Q1 2024 - Operating loss decreased to $23,000 from $144,000 - Net loss improved to $412,000 ($0.02 per share) from $1.5 million ($0.06 per share) - Working capital declined 29% to $10.3 million from $14.7 million

The revenue decline was primarily attributed to decreased US drilling activity, with US fluid distribution sales down 15%. Canadian operations remained relatively stable, while US blending and packaging sales increased by $552,000. The company maintains a cautious outlook due to commodity price volatility and political uncertainty in both US and Canadian markets.

Cenatex Holdings LLC has increased its stake in Bri-Chem Corp. (BRYFF) through two transactions. The company purchased 500 common shares at an average price of $0.1994 USD per share, totaling $99.70 USD. Additionally, Joint Actors Barry Hugghins and related IRA accounts transferred 1,120,820 common shares to Cenatex. Following these transactions, Cenatex now owns 3,701,040 common shares, representing 14.0016% of Bri-Chem's total outstanding shares of 26,432,981.

The transfer of shares from Joint Actors was done to streamline management of holdings. Cenatex indicates it may further adjust its position in Bri-Chem based on various factors including market conditions, price, availability of shares, and company developments.